United States · 
Who invested in Faeth Therapeutics?
Faeth Therapeutics's investors include Khosla Ventures, B Capital, S2G Investments, Digitalis Ventures and KdT Ventures.
United States · Series A startup
Who invested in Faeth Therapeutics
Funding summaryUpdated 26 Oct 2026
$25Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $25MOct 2025
- Investors
- 5
The rounds
- Oct 2025Series A$25M
Source recordedSEC filing: $24M sold, first sale Aug 2025
Founders and team
From Faeth Therapeutics's own website: 3 on the team.
- Alan SunHead of Product
- Sekhar MothaliHead of Engineering
- Saira RamasastryDirector
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 4 firms list Faeth Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Faeth Therapeutics
How much has Faeth Therapeutics raised?
Faeth Therapeutics has raised $25M across 1 round since 2025.
When did Faeth Therapeutics last raise?
Faeth Therapeutics's most recent round was a Series A of $25M in Oct 2025.
What was Faeth Therapeutics's biggest round?
Its most recent round, $25M in Oct 2025, is also its largest on record.
Who backed Faeth Therapeutics first?
Faeth Therapeutics's first round on record, in Oct 2025, was backed by Khosla Ventures, B Capital and S2G Investments and 2 others.
What stage is Faeth Therapeutics at?
Faeth Therapeutics's latest named round is a Series A, in Oct 2025.
Where is Faeth Therapeutics based?
Faeth Therapeutics is based in the United States.
Companies like Faeth Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.